B
6L7A
vs
BSX
BSX
Over the past 12 months, 6L7A has underperformed BSX, delivering a return of 0% compared to the BSX's 27% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
BSX
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc
F:6L7A
|
0.35
EUR
|
|||||
|
Boston Scientific Corp
NYSE:BSX
|
72.315
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
6L7A, BSX
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
B
|
Bellerophon Therapeutics Inc
Revenue
|
|||||||||||
|
Boston Scientific Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
6L7A, BSX
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
B
|
Bellerophon Therapeutics Inc
F:6L7A
|
|||||||||
|
Boston Scientific Corp
NYSE:BSX
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Boston Scientific Corp | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Boston Scientific Corp | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Boston Scientific Corp | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Boston Scientific Corp | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Boston Scientific Corp | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Boston Scientific Corp | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Boston Scientific Corp | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Boston Scientific Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
6L7A, BSX
Performance Gap
6L7A, BSX
Performance By Year
6L7A, BSX
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
|
| US |
|
Resmed Inc
NYSE:RMD
|